| Literature DB >> 11878771 |
R Roccasecca1, A Folgori, B B Ercole, G Puntoriero, A Lahm, S Zucchelli, R Tafi, M Pezzanera, G Galfre, A Tramontano, M U Mondelli, A Pessi, A Nicosia, R Cortese, A Meola.
Abstract
Hepatitis C Virus (HCV) is a major cause of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma, worldwide, and the development of an effective vaccine represents a high priority goal. The Hyper Variable Region 1 (HVR1) of the second Envelope protein (E2) of HCV contains a principal neutralizing determinant, but it is highly variable among different isolates and it is involved in the escape from host immune response. Thus, to be effective, a vaccine should elicit a cross-reacting humoral response against the majority of viral variants. We show that it is possible to achieve a broadly cross-reactive immune response in rabbits by immunization with mimotopes of the HVR1. selected from a specialized phage library using HCV patients' sera. At least some of the cross-reacting anti-mimotope antibodies, elicited in rabbits, recognize discontinuous epitopes in a manner similar to those induced by the virus in infected patients.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11878771 DOI: 10.3109/08830180109043040
Source DB: PubMed Journal: Int Rev Immunol ISSN: 0883-0185 Impact factor: 5.311